F93.0 F93.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - ICD 10: F93.0 or F93.2 (main diagnosis for child-DIPS) - Parental caregiver agrees to their involvement in therapy and is willing to fill out online questionnaires - Child must be able to attend weekly sessions (50 min.), and to fill out online questionnaires - Indications for outpatient treatment is given Online-Questionnaires: http://kp.psycho.uni-duesseldorf.de/schematherapiestudie_assessment_kind/ (10 y and older) http://kp.psycho.uni-duesseldorf.de/schematherapiestudie_check_up_kind/ http://kp.psycho.uni-duesseldorf.de/schematherapiestudie_assessment_eltern/ http://kp.psycho.uni-duesseldorf.de/schematherapiestudie_check_up_eltern/
Exclusion criteria
Exclusion criteria: - Pervasive developmental disorders (ICD 10: F84.-) - IQ below 80 - Severity of the disorder requires immediate inpatient treatment - Parental caregiver shows low compliance to cooperate or is, due to his/her own psychiatric disorders (e.g., borderline personality disorder, depression) not able to cooperate and support the necessary steps (e.g. mode work or graduated exposure of the child in typical fear situations)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DV 1: Assessment of the individual anxiety scale (typical situation, range: 0-100); if two situations were named before the therapy, average of them both (weekly measurement) | — |
Secondary
| Measure | Time frame |
|---|---|
| DV 2: DISYPS-II: Total scale ANZ DV 3: DISYPS-II: Specific anxiety scale ANZ / SOZ, i.e. Scale for separation/ social anxiety DV 4: DISYPS-II: Competence Scale DV 5: SDQ: Total Problem Scale DV 6: WHO5: Total scale (weekly measurement) DV 7: Childlike acceptance of therapy (weekly measurement) DV 8: Parental acceptance of parent work in therapy (measurement after each parents session) DV 9: drop out of therapy or admission into an indoor facility (eg psychiatry) because of anxiety-related problems DISYPS-II and SDQ: altogether 7 x - before and after baseline (T0, T1) - after treatment ST or CBT (T2) - after CBT (in ST-group) or TSF in CBT-group(T3) - Follow-up: 6, 12, 36 months after termination of therapy (T4, T5, T6) | — |
Countries
Germany
Contacts
Heinrich-Heine-Universität DüsseldorfInstitut für Experimentelle PsychologieAbteilung für Klinische Psychologie